Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), & International Conference on Harmonisation. (1997). Guidance for industry: S1B testing for carcinogenicity of pharmaceuticals. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), and International Conference on Harmonisation. Guidance for Industry: S1B Testing for Carcinogenicity of Pharmaceuticals. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 1997.
MLA (9th ed.) CitationCenter for Drug Evaluation and Research (U.S.), et al. Guidance for Industry: S1B Testing for Carcinogenicity of Pharmaceuticals. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 1997.